Joseph E. Rittiner

960 total citations
14 papers, 340 citations indexed

About

Joseph E. Rittiner is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Joseph E. Rittiner has authored 14 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Physiology. Recurrent topics in Joseph E. Rittiner's work include CRISPR and Genetic Engineering (6 papers), Adenosine and Purinergic Signaling (3 papers) and Virus-based gene therapy research (3 papers). Joseph E. Rittiner is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), Adenosine and Purinergic Signaling (3 papers) and Virus-based gene therapy research (3 papers). Joseph E. Rittiner collaborates with scholars based in United States and Australia. Joseph E. Rittiner's co-authors include Mark J. Zylka, Emily A. Hull-Ryde, Stephen V. Frye, William P. Janzen, Ilia Korboukh, Jian Jin, Boris Kantor, Bruce M. Cohen, Christina L. Nemeth and Bryan L. Roth and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Joseph E. Rittiner

11 papers receiving 337 citations

Peers

Joseph E. Rittiner
Carola J. Maturana United States
Joseph E. Rittiner
Citations per year, relative to Joseph E. Rittiner Joseph E. Rittiner (= 1×) peers Carola J. Maturana

Countries citing papers authored by Joseph E. Rittiner

Since Specialization
Citations

This map shows the geographic impact of Joseph E. Rittiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph E. Rittiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph E. Rittiner more than expected).

Fields of papers citing papers by Joseph E. Rittiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph E. Rittiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph E. Rittiner. The network helps show where Joseph E. Rittiner may publish in the future.

Co-authorship network of co-authors of Joseph E. Rittiner

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph E. Rittiner. A scholar is included among the top collaborators of Joseph E. Rittiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph E. Rittiner. Joseph E. Rittiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kantor, Boris, et al.. (2024). The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders. Nature Communications. 15(1). 7259–7259. 12 indexed citations
2.
Kantor, Boris, Joseph E. Rittiner, Bernadette O’Donovan, & Ornit Chiba‐Falek. (2023). APOE‐targeted epigenome therapy for late onset Alzheimer’s disease. Alzheimer s & Dementia. 19(S21). 1 indexed citations
3.
Kantor, Boris, Joseph E. Rittiner, P J Nicholls, & Ornit Chiba‐Falek. (2022). APOE‐targeted epigenome therapy for late onset Alzheimer’s disease. Alzheimer s & Dementia. 18(S10).
4.
Rittiner, Joseph E., et al.. (2022). Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs. Frontiers in Bioengineering and Biotechnology. 10. 1035543–1035543. 20 indexed citations
5.
Helseth, Ashley, Ricardo Hernández, Victoria L. Hall, et al.. (2021). Cholinergic neurons constitutively engage the ISR for dopamine modulation and skill learning in mice. Science. 372(6540). 33 indexed citations
6.
Caffall, Zachary F., Bradley J. Wilkes, Ricardo Hernández, et al.. (2021). The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia. Science Translational Medicine. 13(607). 17 indexed citations
7.
Rittiner, Joseph E., et al.. (2020). Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases. Frontiers in Molecular Neuroscience. 13. 148–148. 35 indexed citations
9.
Korboukh, Ilia, Vincent Setola, Stephen V. Frye, et al.. (2020). Orally Active Adenosine A 1 Receptor Agonists with Antinociceptive Effects in Mice. UNC Libraries.
10.
Rittiner, Joseph E., et al.. (2014). Overexpression of Diacylglycerol Kinase η Enhances Gαq-Coupled G Protein–Coupled Receptor Signaling. Molecular Pharmacology. 85(5). 800–810. 9 indexed citations
11.
Coutinho‐Budd, Jaeda, et al.. (2013). Biological constraints limit the use of rapamycin-inducible FKBP12-Inp54p for depleting PIP2 in dorsal root ganglia neurons. Journal of Negative Results in BioMedicine. 12(1). 13–13. 6 indexed citations
12.
Rittiner, Joseph E., Ilia Korboukh, Emily A. Hull-Ryde, et al.. (2012). AMP Is an Adenosine A1 Receptor Agonist. Journal of Biological Chemistry. 287(8). 5301–5309. 108 indexed citations
13.
Korboukh, Ilia, Emily A. Hull-Ryde, Joseph E. Rittiner, et al.. (2012). Orally Active Adenosine A1Receptor Agonists with Antinociceptive Effects in Mice. Journal of Medicinal Chemistry. 55(14). 6467–6477. 22 indexed citations
14.
Nemeth, Christina L., Tracie A. Paine, Joseph E. Rittiner, et al.. (2010). Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats. Psychopharmacology. 210(2). 263–274. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026